These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12389291)

  • 21. The controversy surrounding bone morphogenetic proteins in the spine: a review of current research.
    Hustedt JW; Blizzard DJ
    Yale J Biol Med; 2014 Dec; 87(4):549-61. PubMed ID: 25506287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological approaches to spinal instrumentation and fusion in spinal deformity surgery.
    Mummaneni PV; Meyer SA; Wu JC
    Clin Neurosurg; 2011; 58():110-6. PubMed ID: 21916134
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?
    Szpalski M; Gunzburg R
    Acta Orthop Belg; 2005 Apr; 71(2):133-48. PubMed ID: 16152845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What bone graft substitutes should we use in post-traumatic spinal fusion?
    Guerado E; Fuerstenberg CH
    Injury; 2011 Sep; 42 Suppl 2():S64-71. PubMed ID: 21839997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone morphogenic proteins (BMPs) and bone repair].
    Marie P
    Rev Chir Orthop Reparatrice Appar Mot; 2000 Sep; 86 Suppl 1():151-2. PubMed ID: 11084518
    [No Abstract]   [Full Text] [Related]  

  • 30. Is off-label use of BMP in pediatric spine surgery now a standard of care? Commentary on an article by Amit Jain, MD, et al.: "Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery. an analysis of 4817 patients".
    Haft GF
    J Bone Joint Surg Am; 2013 Jul; 95(14):e103 1-2. PubMed ID: 23864186
    [No Abstract]   [Full Text] [Related]  

  • 31. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
    Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
    Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion.
    Vaccaro AR; Anderson DG; Toth CA
    Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S59-65. PubMed ID: 12205422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
    Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
    J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species.
    Boden SD; Schimandle JH; Hutton WC
    Spine (Phila Pa 1976); 1995 Dec; 20(24):2633-44. PubMed ID: 8747241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anterior lumbar interbody fusion with osteoinductive growth factors.
    Sandhu HS
    Clin Orthop Relat Res; 2000 Feb; (371):56-60. PubMed ID: 10693550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of Percutaneous Posterolateral Spinal Fusion With Recombinant Bone Morphogenetic Protein-2 (rhBMP-2): A Comparison With Standard Methods Using an Animal Model Study.
    Chan CY; Kwan MK; Saw LB; Paisal H
    Clin Spine Surg; 2017 Mar; 30(2):E138-E147. PubMed ID: 28207623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of human bone morphogenetic proteins in spinal fusion.
    Zlotolow DA; Vaccaro AR; Salamon ML; Albert TJ
    J Am Acad Orthop Surg; 2000; 8(1):3-9. PubMed ID: 10666648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
    Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
    Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal and Spatial Expression of BMPs and BMP Antagonists During Posterolateral Lumbar Fusion.
    Tang Y; Ye X; Klineberg EO; Curtiss S; Maitra S; Gupta MC
    Spine (Phila Pa 1976); 2011 Feb; 36(4):E237-44. PubMed ID: 21099737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of bone morphogenetic protein in spine fusion.
    Hsu WK; Wang JC
    Spine J; 2008; 8(3):419-25. PubMed ID: 18375186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.